Literature DB >> 27477827

Considering Ranolazine as a Potential Treatment for K+ Channel Linked Short QT Syndrome.

Jules C Hancox1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27477827     DOI: 10.1111/jce.13055

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


× No keyword cloud information.
  1 in total

1.  Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome.

Authors:  Meng-Yao An; Kai Sun; Yan Li; Ying-Ying Pan; Yong-Qiang Yin; Yi Kang; Tao Sun; Hong Wu; Wei-Zhen Gao; Jian-Shi Lou
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.